EP1828155A4 - Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use - Google Patents

Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use

Info

Publication number
EP1828155A4
EP1828155A4 EP05851657A EP05851657A EP1828155A4 EP 1828155 A4 EP1828155 A4 EP 1828155A4 EP 05851657 A EP05851657 A EP 05851657A EP 05851657 A EP05851657 A EP 05851657A EP 1828155 A4 EP1828155 A4 EP 1828155A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
nitric oxide
oxide donor
donor groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05851657A
Other languages
German (de)
French (fr)
Other versions
EP1828155A2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Nicox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox SA filed Critical Nicox SA
Priority claimed from PCT/US2005/041321 external-priority patent/WO2006055542A2/en
Publication of EP1828155A2 publication Critical patent/EP1828155A2/en
Publication of EP1828155A4 publication Critical patent/EP1828155A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
EP05851657A 2004-11-15 2005-11-15 Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use Withdrawn EP1828155A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62717704P 2004-11-15 2004-11-15
PCT/US2005/041321 WO2006055542A2 (en) 2004-11-15 2005-11-15 Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use

Publications (2)

Publication Number Publication Date
EP1828155A2 EP1828155A2 (en) 2007-09-05
EP1828155A4 true EP1828155A4 (en) 2011-04-20

Family

ID=38325889

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05851657A Withdrawn EP1828155A4 (en) 2004-11-15 2005-11-15 Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use

Country Status (1)

Country Link
EP (1) EP1828155A4 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004041803A1 (en) * 2002-11-05 2004-05-21 Merck Frosst Canada & Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
WO2005023183A2 (en) * 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004041803A1 (en) * 2002-11-05 2004-05-21 Merck Frosst Canada & Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
WO2005023183A2 (en) * 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BURGAUD J L ET AL: "NITRIC-OXIDE RELEASING MOLECULES: A NEW CLASS OF DRUGS WITH SEVERAL MAJOR INDICATIONS", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, NL, vol. 8, no. 3, 1 January 2002 (2002-01-01), pages 201 - 213, XP001122072, ISSN: 1381-6128, DOI: 10.2174/1381612023396357 *
PRANDI C ET AL: "Development of Absorption Furosemide Prodrugs: Synthesis, In Vitro and in Vivo Evaluation", FARMACO, SOCIETA CHIMICA ITALIANA, PAVIA, IT, vol. 47, no. 2, 1 January 1992 (1992-01-01), pages 249 - 263, XP007917297, ISSN: 0014-827X *

Also Published As

Publication number Publication date
EP1828155A2 (en) 2007-09-05

Similar Documents

Publication Publication Date Title
EP1855688A4 (en) Nitric oxide enhancing diuretic compounds, compositions and methods of use
IL176571A0 (en) Substituted azole derivatives, compositions, and methods of use
EP1497268A4 (en) Nitric oxide donors, compositions and methods of use
PL382308A1 (en) Heterocyclic compounds and the manners of use
IL177513A0 (en) Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
ZA200608028B (en) Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
IL180286A0 (en) Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
ZA200700709B (en) Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
ZA200700706B (en) Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
IL179595A0 (en) Substituted indazoles, compositions containing same, preparation and use
EP1828953A4 (en) Riboswitches, structure-based compound design with riboswitches, and methods and compositions for use of and with riboswitches
EP1626717A4 (en) Benzimidazoles, compositions containing such compounds and methods of use
HK1115309A1 (en) Modified powder and cosmetic composition using same
EP1790639A4 (en) Compound containing basic group and use thereof
HK1105202A1 (en) Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
EP1846380A4 (en) Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use
IL174215A0 (en) Benzimidazole derivatives, compositions containing them preparation thereof and uses thereof
IL172027A0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
IL182126A (en) Compositions containing 5-phenoxyalkoxypsoralen derivatives and uses thereof
PL1828137T3 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
EP1797077A4 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
IL176993A0 (en) Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
EP1828155A4 (en) Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use
EP1790329A4 (en) Humectant containing alpha-glycosyl glycyrrhizin as active ingrediant and use thereof
HK1107256A1 (en) Compositions containing nicorandil, preparation method and use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070615

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NICOX S.A.

A4 Supplementary search report drawn up and despatched

Effective date: 20110323

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/41 20060101ALI20110317BHEP

Ipc: C07D 285/16 20060101AFI20070704BHEP

Ipc: A61K 31/54 20060101ALI20110317BHEP

Ipc: C07D 411/12 20060101ALI20110317BHEP

Ipc: A61K 31/4245 20060101ALI20110317BHEP

Ipc: C07D 295/00 20060101ALI20110317BHEP

Ipc: C07D 269/00 20060101ALI20110317BHEP

Ipc: A61K 31/5375 20060101ALI20110317BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110601